Search for: "Bristol-Myers Squibb"
Results 221 - 240
of 863
Sorted by Relevance
|
Sort by Date
13 Nov 2021, 8:04 pm
Serena Farquharson-Torres of Bristol-Myers Squibb Co.; Sophia Piliouras of Minority Corporate Counsel Association; Elaine Spector of Harrity & Harrity, LLP; and Christopher Suarez of Steptoe & Johnson LLP will provide practical insights and tips to lawyers who seek to improve their practices by becoming better stewards of diversity and inclusion in... [read post]
27 Jun 2017, 8:00 am
On June 19, 2017, the Supreme Court reinforced its narrow application of specific jurisdiction in mass tort proceedings in an 8-1 decision in Bristol-Myers Squibb Company v. [read post]
9 Jun 2018, 8:58 pm
Paul Golian of Bristol-Myers Squibb Company, Ali Salimi of the U.S. [read post]
25 Jun 2021, 4:15 am
., Bristol-Myers Squibb Company, Corning Incorporated, and Merck Sharp & Dohme Corp. filed amicus briefs. [read post]
9 Nov 2011, 9:59 pm
., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership ("Sanofi"); affirmed the District Court's denial of a motion for leave to file a supplemental answer, affirmative defenses, and counterclaims by Defendants-Appellants Apotex Inc. and Apotex Corp. [read post]
7 Nov 2019, 8:10 pm
Companies declining included Bristol-Myers Squibb, 7.9%; Pfizer, 6.9%; and Bayer AG 4.9%. [read post]
15 Jan 2022, 8:42 pm
Elsby of Akin Gump will moderate a panel consisting of Paul Golian of Bristol Myers Squibb and Paula Fritsch of Amgen. [read post]
5 Aug 2013, 9:59 pm
The UK High Court recently gave its judgment in the case of Merck, Sharp & Dohme Corp. and Bristol-Myers Squibb Pharmaceuticals Ltd (collectively referred to in the judgement as BMS) v Teva Pharma B.V. and Teva UK Ltd (Teva) (decision). [read post]
21 Nov 2022, 8:49 am
Ct. 1017), and Bristol-Myers Squibb Co. v. [read post]
27 Jun 2017, 8:00 am
On June 19, 2017, the Supreme Court reinforced its narrow application of specific jurisdiction in mass tort proceedings in an 8-1 decision in Bristol-Myers Squibb Company v. [read post]
10 Mar 2018, 9:12 pm
Eldora Ellison of Sterne Kessler Goldstein & Fox, PLLC will moderate a panel consisting of Brian Walsh of Bristol-Myers Squibb Company, Andrew Trask of Google LLC, and Jonathan Strang of Latham & Watkins LLP. [read post]
20 Jul 2014, 9:38 pm
Paul Golian of Bristol-Myers Squibb Co. will moderate a panel consisting of Aaron Barkoff of McAndrews, Held & Malloy, Ltd.; Grantland Drutchas of McDonnell Boehnen Hulbert & Berghoff LLP; and Michael Fuller of Knobbe, Martens, Olson and Bear, L.L.P, which will focus on the rapidly increasing use of IPRs to invalidate pharmaceutical patents in ANDA litigation. [read post]
28 Apr 2020, 6:31 am
MDT, noon PDT), Tuesday, May 5; Alexi Lahav (UConn) will discuss Bristol-Myers Squibb: Going Forward. [read post]
3 May 2011, 7:53 am
While we applaud Bristol-Myers Squibb for its action, the problem is one that illustrates problems within the medical prescribing community. [read post]
7 Feb 2019, 5:36 pm
Bristol-Myers Squibb Co. [read post]
9 May 2014, 1:09 pm
Bristol-Myers Squibb, No. 13-1948 (1st Cir. [read post]
24 Jul 2012, 8:18 am
Bristol-Myers Squibb Co. v. [read post]
19 Jun 2017, 1:54 pm
Following up on Howard’s and Stephen’s posts about Bristol-Myers, I think the best thing that can be said about the case is that it creates work for more lawyers in more cases. [read post]
29 Jun 2017, 2:29 pm
Seyfarth Synopsis: In Bristol-Myers Squibb Company v. [read post]
31 Aug 2006, 6:15 pm
Sanofi-Aventis SA and Bristol-Myers Squibb sought the preliminary injunction against Apotex Inc . to stop sales of the generic drug citing the likelihood that they will prevail in the patent case and that Apotex's launch last week is causing them irreparable harm. [read post]
